Join ABL at BIO in Philadelphia
Philadelphia, PA – June 11, 2015 – Come to ABL’s booth (#3632) at the BIO International Convention in Philadelphia, PA June 15-18. ABL representatives will be available to discuss ABL’s preclinical and clinical immunological testing, cGMP biomanufacturing services, and potential partnerships. ABL now has sites in the US and France in order to better serve our clients’ global programs.
The 2015 BIO Exhibition will feature more than 1,700 exhibitors and approximately 160,000 square feet. The exhibition also includes 60+ state, regional and country pavilions who in turn host many companies from their regions.
Set up a meeting with us or stop by the booth.
About ABL, Inc.
ABL, Inc. is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics and other biologic products. ABL has extensive experience working with diverse organizations, including the U.S. Government, biopharmaceutical companies and academic entities. Notable contract manufacturing services include process and assay development, cGMP biologics manufacturing of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC analytics in the U.S. and Europe. ABL also maintains U.S. and European immunological and molecular laboratories to support preclinical and GCLP clinical sample processing and testing. ABL is a part of the Institut Mérieux, a group of companies dedicated to developing translational science for better patient care globally.
For more information visit www.ablinc.com or email us.
